Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Quantum Biopharma ( (TSE:QNTM) ) just unveiled an announcement.
On May 19, 2025, Quantum BioPharma Ltd. announced the purchase of an additional USD $1 million in Bitcoin and other cryptocurrencies, bringing their total investment in digital assets to USD $4.5 million. This strategic move is aimed at leveraging the potential returns and hedging against the Canadian dollar while allowing for cryptocurrency-based financing and transactions. The company ensures compliance with financial regulations and may adjust its cryptocurrency holdings based on market conditions.
More about Quantum Biopharma
Quantum BioPharma Ltd. is a biopharmaceutical company focused on developing innovative treatments for neurodegenerative and metabolic disorders, as well as alcohol misuse disorders. The company is advancing its lead compound, Lucid-MS, which targets multiple sclerosis, and maintains strategic investments through its subsidiary, FSD Strategic Investments Inc.
YTD Price Performance: 145.13%
Average Trading Volume: 8,925
Technical Sentiment Signal: Sell
Current Market Cap: C$32.98M
For an in-depth examination of QNTM stock, go to TipRanks’ Stock Analysis page.